Hybridoma Antibody to Breast Cancer Immune Complexes
- 1 January 1982
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 1 (3) , 275-282
- https://doi.org/10.1089/hyb.1.1982.1.275
Abstract
Hybridoma clones were established by fusing spleen cells from mice immunized with purified breast cancer-related immune complexes to drug-resistant nonproducing myelomas. Hybridoma cultures were evaluated for antibody production using immunofluorescence, radioimmunoassay and immunoperoxidase techniques. One antibody demonstrated strong reactivity against breast tumor cells (BT-20) in culture and also was found to bind ductal epithelial cells within sections of human mammary tissue. Antigen was detected within the soluble fraction of breast tumors with molecular weight greater than 500 K. The possible relationship between antigen detected in breast tumor cells and in immune-complexed form is discussed.This publication has 7 references indexed in Scilit:
- Isoelectric focusing analysis of soluble immune complexes bound to Protein A-sepharoseAnalytical Biochemistry, 1981
- Isoelectric focusing — A new approach to the study of immune complexesJournal of Immunological Methods, 1980
- Indirect 125I-labeled protein A assay for monoclonal antibodies to cell surface antigensJournal of Immunological Methods, 1979
- Characterization of immune complexes from the pleural effusion of a breast cancer patientInternational Journal of Cancer, 1978
- A Method of Trace Iodination of Proteins for Immunologic StudiesInternational Archives of Allergy and Immunology, 1966
- Selection of Hybrids from Matings of Fibroblasts in vitro and Their Presumed RecombinantsScience, 1964